Sumita Ray

Sumita Ray

Compliance Officer at CUE BIOPHARMA, INC.

Net worth: 1 M $ as of 31/05/2026

52 year
Health Technology
Consumer Services

Profile

Sumita Ray is currently Independent Director at Biomea Fusion, Inc. since 2021, Chief Legal & Administrative Officer at Vaxxinity, Inc. since 2023, Principal at Fifthray Consulting LLC since 2015, and Secretary, Chief Legal & Compliance Officer at Cue Biopharma, Inc. starting in 2026.
Former roles include Corporate Counsel at Genentech, Inc. from 2007 to 2010, Chief Compliance Officer at Pharmacyclics LLC, Head-BioNeurology & Regulatory Law Group at Elan Pharmaceuticals LLC from 2010 to 2013, Counsel at AstraZeneca LP from 2005 to 2007, Chief Compliance Officer, SVP & General Counsel at Calithera Biosciences, Inc. from 2017 to 2022, Chief Legal, Compliance & Administrative Officer at Instil Bio, Inc. from 2022 to 2023, and Chief Compliance Officer at Pharmacyclics, Inc. Education includes undergraduate studies at the University of Arizona and graduate studies at Temple University Beasley School of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/06/2026 54,589 ( 1.35% ) 1 M $ 31/05/2026
31/03/2026 0 ( -.--% ) - $ 31/05/2026

Sumita Ray active positions

CompaniesPositionStart
BIOMEA FUSION, INC. Director/Board Member 16/06/2021
VAXXINITY, INC. Chief Administrative Officer 01/10/2023
CUE BIOPHARMA, INC. Compliance Officer 01/06/2026

Former positions of Sumita Ray

CompaniesPositionEnd
INSTIL BIO, INC. Chief Administrative Officer 09/05/2023
CALITHERA BIOSCIENCES, INC. Chief Administrative Officer 01/04/2022
Compliance Officer 01/05/2015
Corporate Officer/Principal 01/04/2013
General Counsel 01/05/2010
See the detail of Sumita Ray's experience

Training of Sumita Ray

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!